Are Antibiotics of Value for a Whipple Procedure?
Pancreatoduodenectomy
Perioperative antibiotics
Piperacillin-tazobactam
SSI
Surgical prophylaxis
Zosyn
Journal
Advances in surgery
ISSN: 1878-0555
Titre abrégé: Adv Surg
Pays: United States
ID NLM: 0045335
Informations de publication
Date de publication:
Sep 2024
Sep 2024
Historique:
medline:
2
8
2024
pubmed:
2
8
2024
entrez:
1
8
2024
Statut:
ppublish
Résumé
Pancreatoduodenectomy is a complex surgical procedure with a high rate of morbidity, of which surgical-site infections (SSIs) make a large portion. Reduction of SSI rates is critical to decrease hospital lengths of stay, readmissions, delays in adjuvant therapies, and financial health care burden. Current clinical guidelines recommend the administration of cefoxitin as surgical prophylaxis prior to pancreatoduodenectomy. In April 2023, a randomized controlled trial was published in JAMA which showed that piperacillin-tazobactam as perioperative surgical prophylaxis prior to pancreatoduodenectomy decreased 30 day SSI rates (primary outcome), clinically relevant postoperative pancreatic fistula, postoperative sepsis, and Clostridium difficile infection rates.
Identifiants
pubmed: 39089788
pii: S0065-3411(24)00006-X
doi: 10.1016/j.yasu.2024.04.006
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Cefoxitin
6OEV9DX57Y
Piperacillin, Tazobactam Drug Combination
157044-21-8
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
79-85Informations de copyright
Copyright © 2024 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Disclosure The authors have nothing to disclose.